These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 353964)

  • 1. [Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
    Bordier P; Miravet L; Marie P; Guéris J; Rousselet F; Norman A; Rasmussen H; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1978 Apr; 45(4):241-8. PubMed ID: 353964
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

  • 3. 24,25-Dihydroxycholecalciferol treatment of osteomalacia: use in a patient with vitamin D deficiency and hyperparathyroidism.
    Silver J; Zimmerman J; Sela J; Rubinger D; Friedlaender MM; Popovtzer MM
    Isr J Med Sci; 1984 May; 20(5):437-9. PubMed ID: 6332095
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence that different vitamin D sterols have qualitatively different effects in man.
    Rasmussen H; Bordier P
    Contrib Nephrol; 1980; 18():184-91. PubMed ID: 7353375
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of vitamin D metabolites in humans.
    Rasmussen H; Bordier P; Marie P; Miravet L; Ryckwaert A
    Trans Assoc Am Physicians; 1977; 90():380-9. PubMed ID: 611668
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone.
    Fujita T; Nomura M; Okajima S; Furuya H
    J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.
    Brickman AS; Sherrard DJ; Jowsey J; Singer FR; Baylink DJ; Maloney N; Massry SG; Norman AW; Coburn JW
    Arch Intern Med; 1974 Nov; 134(5):883-8. PubMed ID: 4613310
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.
    Bordier P; Pechet MM; Hesse R; Marie P; Rasmussen H
    N Engl J Med; 1974 Oct; 291(17):866-71. PubMed ID: 4415589
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH; Goldstein DA; Massry SG
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to vitamin D and parathyroid hormone.
    Moses AM
    N Engl J Med; 1978 Aug; 299(8):423-4. PubMed ID: 209328
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
    Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
    Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proximal tubular acidosis associated with deficiency osteomalacia in adults].
    Cogan E; Gillet C; Deschepper C; Karmali R; Fuss M; Corvilain J
    Rev Med Brux; 1987; 8(6-7):367-70. PubMed ID: 3671929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum parathyroid hormone concentrations in hypophosphataemic vitamin D resistant rickets.
    Fanconi A; Fischer JA; Prader A
    Helv Paediatr Acta; 1974 Aug; 29(3):187-94. PubMed ID: 4369169
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of 1,25(OH)2D3 on bone mineralization in vitamin D deficiency (author's transl)].
    Rombouts-Lindemans C; Huaux JP; Meersseman F; Withofs H; Nagant de Deuxchaisnes C
    Ann Endocrinol (Paris); 1979; 40(2):173-4. PubMed ID: 475313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypophosphatemic vitamin D resistant osteomalacia with parathyroid adenoma (author's transl)].
    Blanc D; Mouries D; Phelip X
    Sem Hop; 1980 Jan 18-25; 56(3-4):184-7. PubMed ID: 6244654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phenytoin on bone and vitamin D metabolism.
    Bell RD; Pak CY; Zerwekh J; Barilla DE; Vasko M
    Ann Neurol; 1979 Apr; 5(4):374-8. PubMed ID: 220903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.